Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liquid ventilation.

J D Ricard1, F Lemaire

  • 1Department of Critical Care, Louis Mourier Hospital, Colombes, and INSERM U82, Paris, France. ricard@bichat.inserm.fr

Current Opinion in Critical Care
|May 25, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the multifunctional potential of tannic acid-crosslinked Wharton's jelly hydrogel as a scaffold for bone regenerative medicine.

International journal of biological macromolecules·2026
Same author

Life-threatening hemophagocytic syndrome triggered by disseminated toxoplasmosis in a young patient with previously unknown AIDS.

La Revue de medecine interne·2022
Same author

Extracorporeal membrane oxygenation for refractory COVID-19 acute respiratory distress syndrome.

Journal of critical care·2020
Same author

[Assessment of a newly-implemented blended teaching of intensive care and emergency medicine at Paris-Diderot University].

La Revue de medecine interne·2020
Same author

Cowries derived aragonite as raw biomaterials for bone regenerative medicine.

Materials science & engineering. C, Materials for biological applications·2018
Same author

Hypothesis: early renal replacement therapy increases mortality in critically ill patients with acute on chronic renal failure. A post hoc analysis of the AKIKI trial.

Intensive care medicine·2018
Same journal

How to establish and run a national ICU benchmarking registry.

Current opinion in critical care·2026
Same journal

Cardiogenic shock - toward phenotype-directed, precision management.

Current opinion in critical care·2026
Same journal

The future of critical care nutrition: from calorie counting to precision personalized metabolism therapy.

Current opinion in critical care·2026
Same journal

Editorial introduction.

Current opinion in critical care·2026
Same journal

Generative artificial intelligence for outcome prediction in critical care: the future is now?

Current opinion in critical care·2026
Same journal

Feeding under support in critical care illness: metabolic and nutritional management during extracorporeal membrane oxygenation and continuous renal replacement therapy.

Current opinion in critical care·2026
See all related articles

Partial liquid ventilation (PLV) using perfluorocarbons (PFCs) shows promise for improving lung function and reducing injury in acute lung injury. Research focuses on optimizing ventilatory strategies and PFC dosage, with clinical trials nearing completion.

Area of Science:

  • Pulmonary Medicine
  • Critical Care Medicine
  • Biomedical Engineering

Background:

  • Partial liquid ventilation (PLV) has emerged as a significant clinical and experimental strategy.
  • Perfluorocarbon (PFC) administration in PLV improves oxygenation and lung mechanics.

Purpose of the Study:

  • To optimize PLV by investigating optimal ventilatory modes and positive end-expiratory pressure (PEEP) levels.
  • To explore other pathophysiological benefits of liquid ventilation in acute lung injury, such as blood flow redistribution and reduced ventilator-induced lung injury.

Main Methods:

  • Animal studies evaluating different ventilatory modes and PEEP levels during PLV.
  • Investigation of PFC's anti-inflammatory properties and effects on regional blood flow.
  • Analysis of baro- and volutrauma associated with varying PFC doses.

Related Experiment Videos

Main Results:

  • PLV demonstrates potential for improved oxygenation and lung mechanics.
  • Smaller PFC doses are suggested to mitigate risks of baro- and volutrauma.
  • Evidence supports beneficial effects on acute lung injury pathophysiology.

Conclusions:

  • PLV is a developing field with promising preclinical and clinical data.
  • Ongoing research aims to refine PLV protocols for enhanced efficacy and safety.
  • An international randomized controlled trial is nearing completion, poised to provide definitive clinical evidence.